JCT  Vol.5 No.10 , September 2014
Polymer Delivery of Hydroxycamptothecin against C6 Glioma
Abstract: Hydroxycamptothecin is a potent antineoplastic agent that has shown efficacy against multiple tumor lines in vitro. This is the first study to investigate the release, distribution, and efficacy of hydroxycamptothecin which was incorporated into the biodegradable polymer Polylactic Acid (PLA), and implant into brain directly. In vitro release curve generated showed that a large initial release occurred over the first three days and was followed by a steady, but considerably slower rate of release over the next 25 days. After implanting the discs into 40 male SD rats, the animals were followed up to 28 days, where the concentration in brain tissue was far higher than that in peripheral blood at the each of the eight time-points evaluated, and it was also within the therapeutic range for C6 cells tested in vitro. The in vivoefficacy of the discs was evaluated with rats inoculated intracranially with C6 glioma and treated with hydroxycamptothecin polymer compared to intravenous as well as intratumoral injections; the median survival is 21.1, 13.9, 14.9 days, respectively. Given these data, we conclude that the biodegradable polymer PLA releases hydroxycamptothecin, producing tumoricidal levels in brain tissues and prolonging survival in a rat glioma model.
Cite this paper: Hu, J. , Tang, H. and Liu, S. (2014) Polymer Delivery of Hydroxycamptothecin against C6 Glioma. Journal of Cancer Therapy, 5, 920-928. doi: 10.4236/jct.2014.510098.

[1]   Menei, P. (2005) Local and Sustained Delivery of 5-Fluorouracil from Biodegradable Microspheres for the Radiosensitization of Malignant Glioma: A Randomized Phase II Trial. Neurosurgery, 56, 242-248.

[2]   Preface (2006) Local Controlled Drug Delivery to the Brain. International Journal of Pharmaceutics, 314, 99-100.

[3]   Storm, P.B., Moriarity, J.L. and Tyler, B. (2002) Polymer Delivery of Camptothecin against 9L Gliosarcoma: Release, Distribution and Efficacy. Neuro-Oncology, 56, 209-217.

[4]   Zhang, Z.W., Patchett, S.E. and Farthing, M.J. (2000) Topoisomerase I Inhibitor (Camptothecin)-Induced Apoptosis in Human Gastric Cancer Cells and the Role of Wild-Type p53 in the Enhancement of Its Cytotoxicity. Anticancer Drugs, 11, 57-64.

[5]   Zhang, R., Li, Y., Cai, Q., Liu, T., Sun, H. and Chambless, B. (1998) Preclinical Pharmacology of the Natural Product Anticancer Agent 10-Hydroxycamptothecin, an Inhibitor of Topoisomerase I. Cancer Chemotherapy and Pharmacology, 41, 257-267.

[6]   Fassberg, J., Stella, V.J., Wang, S.L., Lin, S.Y., Hsieh, T.F. and Chan, S.A. (2007) Thermal Behavior and Thermal Decarboxylation of 10-Hydroxycamptothecin in the Solid State. Journal of Pharmaceutical and Biomedical Analysis, 43, 457-463.

[7]   Takahashi, M., Onishi, H. and Machida, Y. (2004) Development of Implant Tablet for a Week-Long Sustained Release. Journal of Controlled Release, 100, 63-74.

[8]   Gusea, C. and Koennings, S. (2006) Biocompatibility and Erosion Behavior of Implants Made of Triglycerides and Blends with Cholesterol and Phospholipids. International Journal of Pharmaceutics, 314, 153-160.

[9]   Gusea, C. and Koennings, S. (2006) Programmable Implants—From Pulsatile to Controlled Release. International Journal of Pharmaceutics, 314, 161-169.

[10]   Dang, W.B., Daviau, T. and Ying, P. (1996) Effects of GLIADEL® Wafer Initial Molecular Weight on the Erosion of Wafer and Release of BCNU. Journal of Controlled Release, 42, 83-92.

[11]   Ma, M.-F., Yu, T., Dai, S.-J., Wang, Y. and Yan, X.-F. (2002) Determination of Contents of 10-Hydroxycamptothecin in Camptotheca Acuminata by High-Performance Liquid Chromatogram. Journal of Forestry Research, 13, 144-146.

[12]   Naraharisetti, P.K., Ong, B.Y.S. and Xie, J.W. (2007) In Vivo Performance of Implantable Biodegradable Preparations Delivering Paclitaxel and Etanidazole for the Treatment of Glioma. Biomaterials, 28, 886-894.

[13]   Ulmer, S., Reeh, M. and Krause, J. (2008) Dynamic Contrast-Enhanced Susceptibility-Weighted Perfusion MRI (DSC-MRI) in a Glioma Model of the Rat Brain Using a Conventional Receive-Only Surface Coil with a Inner Diameter of 47 mm at a Clinical 1.5 T Scanner. Journal of Neuroscence Methods, 172, 168-172.

[14]   Fu, Y.-R., Yi, Z.-J. and Yan, Y.-R. (2006) Hydroxycamptothecin-Induced Apoptosis in Hepatoma SMMC-7721 Cells and the Role of Mitochondrial Pathway. Mitochondrion, 6, 211-217.

[15]   Zhang, L.Y., Yang, M. and Wang, Q. (2007) 10-Hydroxycamptothecin Loaded Nanoparticles: Preparation and Antitumor Activity in Mice. Journal of Controlled Release, 119, 153-162.

[16]   Vochelle, D. (2004) The Use of Poly-L-Lactic Acid in the Management of Soft-Tissue Augmentation: A Five-Year Experience. Seminars in Cutaneous Medicine and Surgery, 23, 223-226.

[17]   Freitas, M.N. and Marchetti, J.M. (2005) Nimesulide PLA Microspheres as a Potential Sustained Release System for the Treatment of Inflammatory Diseases. International Journal of Pharmaceutics, 295, 201-211.

[18]   Guo, X.D., Zhang, L.J. and Qian, Y. (2007) Effect of Composition on the Formation of Poly(dl-lactide) Microspheres for Drug Delivery Systems: Mesoscale simulations. Chemical Engineering Journal, 131, 195-201.

[19]   Olivi, A., Ewend, M.G., Utsuki, T., Tyler, B., Domb, A.J., Brat, D.J. and Brem, H. (1996) Interstitial Delivery of Carbopla Tin via Biodegradable Polymers Is Effective against Experimental Glioma in the Rat. Cancer Chemotherapy and Pharmacology, 39, 90-96.